5-Amino or substituted amino-7-phenyl or substituted phenyl-2,3-dihydro-1H-1,4-diazepines
Abstract
Compounds of the formula ##STR1## wherein R 1 is hydrogen, alkyl of 1 to 6 carbon atoms or amino, R 2 is hydrogen or alkyl of 1 to 6 carbon atoms, with the provisos that (1) at least one of R 1 and R 2 is not a tertiary alkyl group and (2) R 2 is hydrogen when R 1 is amino, or R 1 and R 2 taken together and with the nitrogen atom to which they are joined are pyrrolidino, piperidino or N'-2-hydroxyethylpiperazino, each X' is independently alkyl or 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halo, or two X's on adjacent carbon atoms together are methylenedioxy, and n is 0, 1, 2 or 3, and the pharmaceutically acceptable acid addition salts thereof, are useful as anti-obesity and anti-diabetic agents. The compounds wherein R 1 is alkyl and R 2 is hydrogen are synthesized by a two-step synthesis from 2-alkyl-5-arylisoxazolium salts and ethylenediamine. The compounds wherein R 1 and R 2 are hydrogen are synthesized by cleaving the t-butyl group from the corresponding compounds wherein R 1 is t-butyl and R 2 is hydrogen. The compounds wherein R 1 is amino are synthesized from the corresponding compounds wherein R 1 is hydrogen or alkyl. All of the compounds are synthesized by reacting ammonia, a suitable amine or hydrazine with a compound of the formula ##STR2## wherein R' is primary or secondary alkyl of 1 to 4 carbon atoms.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound of the formula ##STR43## wherein R 1 is hydrogen, alkyl of 1 to 6 carbon atoms or amino, R 2 is hydrogen or alkyl of 1 to 6 carbon atoms, with the provisos that (1) at least one of R 1 and R 2 is not a tertiary alkyl group and (2) R 2 is hydrogen when R 1 is amino, each X' is independently alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halo, or two X's on adjacent carbon atoms together are methylenedioxy, and n is 0, 1, 2 or 3, or a pharmaceutically acceptable acid addition salt thereof.
2. A pharmaceutically acceptable acid addition salt of a compound according to claim 1.
3. A compound according to claim 1 having the formula ##STR44## wherein R is alkyl of 1 to 6 carbon atoms, each X is independently alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halo, and m is 0, 1 or 2, or a pharmaceutically acceptable acid addition salt thereof.
4. A compound according to claim 3 having the formula ##STR45## wherein R is alkyl of 1 to 6 carbon atoms, and each Y is hydrogen, alkyl of 1 to 3 carbon atoms, methoxy, ethoxy, chloro or bromo, with the proviso that at least one Y is hydrogen, or a pharmaceutically acceptable acid addition salt thereof.
5. A compound according to claim 4 wherein each Y is hydrogen, or a pharmaceutically acceptable acid addition salt thereof.
6. A compound according to claim 1 wherein each X' is independently alkyl of 1 to 3 carbon atoms, methoxy, ethoxy, chloro or bromo, and n is 0, 1 or 2, or a pharmaceutically acceptable acid addition salt thereof.
7. A compound according to claim 6 having the formula ##STR46## wherein R 1 is hydrogen, alkyl of 1 to 6 carbon atoms or amino, and each Y' is independently hydrogen, methyl, ethyl, methoxy or ethoxy, or a pharmaceutically acceptable acid addition salt thereof.
8. A compound according to claim 7 wherein each Y' is independently hydrogen, methyl or methoxy, or a pharmaceutically acceptable acid addition salt thereof.
9. A compound according to claim 7 wherein R 1 is hydrogen or t-butyl, or a pharmaceutically acceptable acid addition salt thereof.
10. A compound according to claim 9 wherein each Y' is independently hydrogen, methyl or methoxy, or a pharmaceutically acceptable acid addition salt thereof.
11. A compound according to claim 10 having the formula ##STR47## wherein R 1 ' is hydrogen or t-butyl, Y 1 is hydrogen, methyl or methoxy, and Y 2 is hydrogen or methyl, or a pharmaceutically acceptable acid addition salt thereof.
12. A pharmaceutically acceptable acid addition salt of a compound according to claim 11.
13. A compound according to claim 11 wherein R 1 ' is hydrogen, or a pharmaceutically acceptable acid addition salt thereof.
14. A pharmaceutically acceptable acid addition salt of a compound according to claim 13.
15. The compound according to claim 13 having the formula ##STR48## or a pharmaceutically acceptable acid addition salt thereof.
16. The compound according to claim 15 having the formula ##STR49##
17. A pharmaceutical acceptable acid addition salt according to claim 15 of the compound of the formula ##STR50##
18. The pharmaceutically acceptable acid addition salt according to claim 17 having the formula ##STR51##
19. The compound according to claim 11 having the formula ##STR52## or a pharmaceutically acceptable acid addition salt thereof.
20. The pharmaceutically acceptable acid addition salt according to claim 19 having the formula ##STR53##
21. The compound according to claim 11 having the formula ##STR54## or a pharmaceutically acceptable acid addition salt thereof.
22. The compound according to claim 21 having the formula ##STR55##
23. A pharmaceutically acceptable acid addition salt according to claim 21 of the compound of the formula ##STR56##
24. The pharmaceutically acceptable acid addition salt according to claim 23 having the formula ##STR57##
25. The pharmaceutically acceptable acid addition salt according to claim 23 having the formula ##STR58##
26. The compound according to claim 11 having the formula ##STR59## or a pharmaceutically acceptable acid addition salt thereof.
27. The pharmaceutically acceptable acid addition salt according to claim 26 having the formula ##STR60##
28. The compound according to claim 11 having the formula ##STR61## or a pharmaceutically acceptable acid addition salt thereof.
29. The pharmaceutically acceptable acid addition salt according to claim 28 having the formula ##STR62##
30. The compound according to claim 11 having the formula ##STR63## or a pharmaceutically acceptable acid addition salt thereof.
31. The pharmaceutically acceptable acid addition salt according to claim 30 having the formula ##STR64##
32. The compound according to claim 8 having the formula ##STR65## or a pharmaceutically acceptable acid addition salt thereof.Join the waitlist — get patent alerts
Track USRE31061E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.